Results 221 to 230 of about 342,419 (394)

PTRF Confers Melanoma‐Acquired Drug Resistance Through the Upregulation of EGFR

Cell Proliferation, EarlyView.
The upregulation of PTRF, a critical caveolar component, and the concomitant increase in caveolae number potentiate cellular proliferation and survival pathways, thereby contributing to melanoma drug resistance. ABSTRACT Melanoma is the most serious type of skin cancer. About half of all melanomas have activating BRAF mutations.
Miao Wang, Ying Cao, Chengcheng Ren, Ke Wang, Yaxiang Wang, Xiaoying Wu, Jian Mao, Qian Liang, Qian Zhang, Hezhe Lu, Xiaowei Xu, Yu‐Sheng Cong   +11 more
wiley   +1 more source

Universal Proteomic Signature After Exercise-Induced Muscle Injury in Muscular Dystrophies. [PDF]

Ann Clin Transl Neurol
Stemmerik MG, Barthel B, Andersen NR, Skriver SV, Russell AJ, Vissing J.   +5 more
europepmc   +1 more source

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network. [PDF]

Neurol Genet, 2023
Kang PB, Jorand-Fletcher M, Zhang W, McDermott SW, Berry R, Chambers C, Wong KN, Mohamed Y, Thomas S, Venkatesh YS, Westfield C, Whitehead N, Johnson NE, Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).   +15 more
europepmc   +1 more source

The Efficacy of Sulphur Amino Acids and Related Compounds for Protection Against the Development of Muscular Dystrophy in the Chick

, 1962
K.J. Jenkins, D.C. Hill, Lilian M. Hutcheson, H.D. Branion   +3 more
openalex   +1 more source

Serum Enzyme Activity in Muscular Dystrophy [PDF]

, 1960
W. H. Thomson, P. Leyburn, J. N. Walton
openalex   +1 more source

Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies

Muscle and Nerve, 2017
Rylie M. Hightower, M. S. Alexander
semanticscholar   +1 more source

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

Cell Proliferation, EarlyView.
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri   +4 more
wiley   +1 more source

Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophies. [PDF]

Front Neurol
Nambu Y, Osawa K, Shirakawa T, Sunami A, Sonehara S, Bo R, Nozu K, Matsuo M, Awano H.   +8 more
europepmc   +1 more source

The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies. [PDF]

Int J Mol Sci, 2023
Zabłocki K, Górecki DC.
europepmc   +1 more source

Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes.

Human Gene Therapy, 2016
E. Negroni, A. Bigot, G. Butler-Browne, C. Trollet, V. Mouly   +4 more
semanticscholar   +1 more source